CN107192695B - Using aggregation-induced emission to crystal growth and conversion fluorescent visual research method - Google Patents
Using aggregation-induced emission to crystal growth and conversion fluorescent visual research method Download PDFInfo
- Publication number
- CN107192695B CN107192695B CN201710303038.XA CN201710303038A CN107192695B CN 107192695 B CN107192695 B CN 107192695B CN 201710303038 A CN201710303038 A CN 201710303038A CN 107192695 B CN107192695 B CN 107192695B
- Authority
- CN
- China
- Prior art keywords
- crystal
- crystal forms
- different crystal
- aggregation
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 101
- 238000000034 method Methods 0.000 title claims abstract description 58
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 25
- 230000000007 visual effect Effects 0.000 title claims abstract description 18
- 238000011160 research Methods 0.000 title claims abstract description 17
- 230000002776 aggregation Effects 0.000 title claims abstract description 13
- 238000004220 aggregation Methods 0.000 title claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 27
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 238000000799 fluorescence microscopy Methods 0.000 claims abstract description 15
- 238000003384 imaging method Methods 0.000 claims abstract description 14
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 5
- 239000012047 saturated solution Substances 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000010583 slow cooling Methods 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 claims description 2
- 229940113088 dimethylacetamide Drugs 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 230000009466 transformation Effects 0.000 abstract description 9
- 230000007246 mechanism Effects 0.000 abstract description 5
- 238000011065 in-situ storage Methods 0.000 abstract description 3
- -1 methoxyl group Chemical group 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 abstract description 2
- 238000012921 fluorescence analysis Methods 0.000 abstract description 2
- 238000011897 real-time detection Methods 0.000 abstract description 2
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- RKCCHOOOPIHOND-HKWRFOASSA-N (2z)-1-phenyl-2-(3-phenyl-1h-quinoxalin-2-ylidene)ethanone Chemical compound C=1C=CC=CC=1C(=O)\C=C1/NC2=CC=CC=C2N=C1C1=CC=CC=C1 RKCCHOOOPIHOND-HKWRFOASSA-N 0.000 description 2
- XXBQLHATYQHJQC-UHFFFAOYSA-N 1,2-dihydroquinoxaline Chemical compound C1=CC=C2N=CCNC2=C1 XXBQLHATYQHJQC-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000005170 crystalloluminescence Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000011066 ex-situ storage Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000103 photoluminescence spectrum Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention belongs to fluorescence analysis detection technique fields, disclose a kind of method realized using aggregation-induced emission property to crystal growth and the research of conversion process fluorescent visual.The present invention distinguishes different crystal forms crystal by different using fluorescence emission wavelengths under compound different crystal forms state, using the method for fluorescence imaging, and/or carries out dynamic imaging tracking to the conversion process of different crystal forms；Compound has structure shown in formula 1:R1It is each independently selected from sulphur atom or NH group；R2It is each independently selected from one of hydrogen atom, methyl, ethyl and methoxyl group.The method of the present invention monitors different crystal forms structure growth and conversion process real-time tracking, can preparing to mechanical scribing method, there is the growth course of the crystal threadiness aggregated structure aligned to carry out fluorescent visual research, have the characteristics that easy to operate, rapid, result is accurate, real-time detection in situ, there is application value in fields such as crystalline state analysis, the researchs of phase transformation mechanism.
Description
Technical field
It is the invention belongs to fluorescence analysis detection technique field, in particular to a kind of to utilize the realization pair of aggregation-induced emission property
The method of crystal growth and the research of conversion process fluorescent visual.
Background technique
The formation and transformation of crystal process for observing crystallization to the theoretic knowledge for deepening crystallization mechanism and pass through crystallization condition
Control obtain target crystal form have vital meaning.The different crystal forms of same molecules are with different physics and chemically
Matter, for example, solubility, fusing point, chemical reactivity, photophysical property, biological medicament utilization rate etc..In pharmaceuticals industry often
It was found that a certain specific crystal formation in polymorphism just has sufficient drug effect, therefore, reasonable control crystallization condition obtains specific
Crystal form to improve drug pharmacological property be with a wide range of applications.
But the shortage of direct observation and follow-up study means to Crystallization and transformation of crystal is still a kind of huge
Big challenge.Traditional means such as single crystal diffraction, X-ray diffraction (XRD), transmission electron microscope (TEM), electronic diffraction (ED) and
Atomic force microscope (AFM) etc. often only to the characterization of crystallization beginning, final state crystal form, only provides the experiment number of indirect ex situ
According to, and the intuitive, observation and description to entire dynamic process especially intermediate state in real time can not be provided, however intermediate state
Observation for in-depth understand crystal formation and transformation mechanism be of crucial importance.In the phase transition process of fluorescent molecule
In, the variation of fluorescence color and efficiency will provide a kind of intuitive fluorescent visual approach.Fluorescent visual method is due to glimmering
The acuteness of light, it is more friendly, quick, inexpensive compared to traditional characterization method, more importantly can provide real-time, former
The observation to entire Crystallization and transformation of crystal of position.
Summary of the invention
In order to overcome the shortcomings and deficiencies of the prior art described above, assemble the primary purpose of the present invention is that providing a kind of utilize
Induced luminescence property realizes the method to crystal growth and the research of conversion process fluorescent visual.
Another object of the present invention is to be to provide a kind of fluorescent emission property of crystal using different crystal forms structure
Difference, realize and tracking be imaged to the real-time Dynamic Fluorescence of different crystal forms structure growth and conversion process.
The purpose of the present invention is realized by following proposal:
A method of it is realized using aggregation-induced emission property and crystal growth and conversion process fluorescent visual is studied,
By different using fluorescence emission wavelengths under compound different crystal forms state, it is brilliant that different crystal forms are distinguished using the method for fluorescence imaging
Body, and/or dynamic imaging tracking is carried out to the conversion process of different crystal forms.
The compound has structure shown in formula 1 or formula 2:
Wherein, R1It is each independently selected from sulphur atom or NH group；R2Be each independently selected from hydrogen atom, methyl, ethyl and
One of methoxyl group.
The compound is preferably 1- phenyl -2- (3- phenyl -2 (1H)-quinoxaline fork)-(2Z)-ethyl ketone (PPQE, Z-
1-phenyl-2-(3-phenylquinoxalin-2(1H)-ylidene)ethan-1-one)。
Described can be by using the ultraviolet of 300~400nm wavelength using fluorescence imaging method differentiation different crystal forms crystal
Light irradiation, visually observes, and according to the difference of the launch wavelength of different crystal forms, realizes the resolution to different crystal forms structural region.
Described can be by using the ultraviolet of 300~400nm wavelength using fluorescence imaging method differentiation different crystal forms crystal
Light irradiation is realized according to the difference of the launch wavelength of different crystal forms to different crystal forms structural area using Induced Fluorescence Microscopy
The resolution in domain.
The conversion process to different crystal forms carries out dynamic imaging tracking can be by using the purple of 300~400nm wavelength
Outer light irradiation carries out Time-resolved imaging using Induced Fluorescence Microscopy, and different crystal forms structure conversion process is moved in realization
State tracking.
Wherein, when preparing the different crystal forms crystal, can by the way that the compound is prepared as hot saturated solution, quickly or
Slow cooling solution, obtains crystal.
Or can be by the way that the compound is prepared as room temperature saturated solution, slow solvent flashing, obtains crystal at room temperature.
Or it then can be immediately placed in liquid nitrogen and be quickly cooled down, obtain without fixed by melting the compound at high temperature
The sample of shape state.
The high-temperature fusion can be 200 DEG C.
Above-mentioned is that solution preferably uses single solvent or mixed solvent.
The solvent may include dimethyl sulfoxide, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide, acetonitrile, methanol,
Ethyl alcohol, normal propyl alcohol, isopropanol, n-butanol, the tert-butyl alcohol, ethyl acetate, 1,4- dioxane, tetrahydrofuran, chloroform, dichloromethane
Alkane, acetone, ether, petroleum ether, n-hexane and hexamethylene etc..
Gained crystal or the sample of amorphous state use the ultraviolet light of 300~400nm wavelength, visually observe, root
According to the difference of the launch wavelength of different crystal forms, the resolution to different crystal forms structural region is realized.
Gained crystal or the sample of amorphous state use the ultraviolet light of 300~400nm wavelength, using fluorescence microscopy
Imaging technique realizes the resolution to different crystal forms structural region according to the difference of the launch wavelength of different crystal forms.
It is above-mentioned that preferably the tiny area of sample is imaged using Induced Fluorescence Microscopy.
Gained crystal or the sample of amorphous state use the ultraviolet light of 300~400nm wavelength, using fluorescence microscopy
Imaging technique carries out Time-resolved imaging, realizes the dynamically track to different crystal forms structure conversion process.
It is above-mentioned that preferably the tiny area of sample is imaged using Induced Fluorescence Microscopy.
Above compound is the molecule with heterocycle structure, is hardly shone in solution and unformed shape, but crystallizing
It can get the aggregation-induced emission property of hyperfluorescence transmitting under state.It can get the compound not by different crystallization conditions
Isomorphous crystal, different crystal forms can change under given conditions, by the difference of the fluorescence emission wavelengths of different crystal forms,
It is convenient to growth and transformation of crystal process to crystal and carries out visualization tracking and monitoring.
In addition, also assembling to prepared by mechanical scribing method with the crystal threadiness aligned using the method for the present invention
The growth course of structure carries out fluorescent visual research.The method of the present invention is stablized with compound used therefor property, and preparation is simple, respectively
The crystal of crystal form prepares convenient and efficient, and different crystal forms crystallo-luminescence nature difference obtained is big, and transformation of crystal process observation is simple
It is convenient, sensitive quick feature is monitored to crystal form conversion process, can be widely applied to crystal habit conversion process research, phase turns
Become the fields such as mechanism study.
The present invention compared with the existing technology, have the following advantages and the utility model has the advantages that
Fluorescent molecule of the present invention with aggregation-induced emission property has preparation method easy to operate, and raw material is easy
, the mild feature of reaction condition.
The method provided by the invention monitored to different crystal forms structure growth and conversion process real-time tracking, has operation letter
Just, rapidly, the characteristics of result is accurate, be not required to be further processed sample, real-time detection in situ.This method is in crystalline state point
The fields such as analysis, the research of phase transformation mechanism have practical application value.
Detailed description of the invention
Fig. 1 is the chemistry and mono-crystalline structures of compound PPQE in embodiment 1, wherein three kinds of different crystals A, B, C's is glimmering
The intermolecular Mathematical Model of heaped-up top view (2) and side view of light microscope photo (1) and three kinds of different crystal A, B, C structure cells
(3)。
Fig. 2 is crystal A, B, C of compound PPQE and the photoluminescence spectra of amorphous state sample in embodiment 1.
Fig. 3 is in embodiment 2, and the conversion process fluorescent visual of monocrystalline of the compound PPQE from crystal C to B to monocrystalline is supervised
Control imaging, A~D are 10 minutes, and E~H is 5 hours, and I~L is 1 day and M~P is 2 days；A~C, E~G, I~K and M~O are days
Photo under light lamp；D, H, L and P are the photos shot under fluorescence microscope.
Fig. 4 is to pass through acetone/tert-butyl alcohol mixed solution of the PPQE in syringe needle scribing solvent volatilization process in embodiment 3
The fluorescent microscopy images of the crystal accumulation line of induced synthesis.
Fig. 5 is in embodiment 4, and the amorphous state sample of the PPQE observed under different multiples fluorescence microscope is with the time
Elapse the process changed to crystalline state.Initial amorphous state sample: emission wavelength lambdaem=595nm, fluorescence quantum yield Φ=
0.8%；Amorphous state sample after being placed at room temperature for 48 hours: emission wavelength lambdaem=566nm, fluorescence quantum yield Φ=
8.5%.
Fig. 6 is principle of the invention effect picture.
Specific embodiment
Below with reference to embodiment, the present invention is described in further detail, and embodiments of the present invention are not limited thereto.
Reagent used in the following example can be obtained from commercial channel.
Embodiment 1
1- phenyl -2- (3- phenyl -2 (1H)-quinoxaline fork)-(2Z)-ethyl ketone, PPQE, Z-1-phenyl-2- (3-
Phenylquinoxalin-2 (1H)-ylidene) ethan-1-one, structural formula:
The preparation of molecule monocrystalline A: 1mL dimethyl sulfoxide solvent is added in 200mg PPQE for method one, heats at 150 DEG C
To being completely dissolved, heating stirring is closed, the Slow cooling in oil bath pan is recrystallized to give orange block-like monocrystalline A；Method two,
It is slowly added to suitable tert-butyl alcohol under slight boiling condition, in PPQE to just dissolving, prepares the hot saturated solution of the tert-butyl alcohol of PPQE,
Then the slow Temperature fall of solution in oil bath pan obtains orange block-like monocrystalline A.
The preparation of PPQE molecule monocrystalline B: the slightly boiled solution of acetonitrile that concentration is 12.5mg/mL PPQE is slow in oil bath pan
Temperature fall is recrystallized to give orange diamond shape monocrystalline B.
The synthesis of PPQE molecule monocrystalline C: the slightly boiled solution of acetonitrile that concentration is 6mg/mL PPQE rapid and natural in air drops
Temperature is recrystallized to give orange whiskers C.
The preparation of PPQE molecule amorphous state sample: PPQE is complete in 200 DEG C of meltings, it is then immediately placed in liquid nitrogen fast
Quickly cooling but obtains the amorphous state sample of red glass shape.See Fig. 1~2.
Embodiment 2
The conversion of PPQE molecule monocrystalline C to monocrystalline B is observed: typical experimental implementation is to heat 100mgPPQE at 80 DEG C
Under the conditions of be dissolved completely in 8mL acetonitrile, the then culture dish of fast transfer to diameter 6cm is quickly cooled down in room temperature.In crystal
Growth and monocrystalline conversion process in, save culture dish strictly seal the volatilization to prevent solvent.So quickly cooling down
Cheng Zhong, acicular monocrystalline C are quickly generated, and then as the propulsion of time, monocrystalline C in situ is to monocrystalline B's in acetonitrile solution
Conversion can be observed directly in room temperature, and carry out the photograph taking under fluorescent lamp and UV lamp irradiation simultaneously in different periods.See
Fig. 3.
Embodiment 3
For PPQE molecule in the crystal growing process in tert-butyl alcohol supersaturated solution, the crystal of metal needle scribing induction is raw
Long and arrangement: by the way that in the PPQE tert-butyl alcohol supersaturated solution in substrate of glass, two tools are can be obtained in metal needle scribing drop
Have a PPQE crystal accumulation line that different shapes are parallel with luminescent color, Green and yellow fluorescence crystal accumulation line respectively by
The crystal form C and A of dynamic stabilization are formed.The observation of this crystal form coherent condition by way of UV light micro-imaging with photo
Shooting approach is recorded.See Fig. 4.
Embodiment 4
The micro- monitoring of the dynamic of PPQE molecule amorphous state to crystalline state: typical experimental implementation is, by 500mg
PPQE is melted completely under 200 DEG C of heating conditions, and then fast transfer is cooling into liquid nitrogen, obtains amorphous state solid as red
Translucent glass shape solid, at room temperature basic unstressed configuration emission characteristic.Microscopic imaging fluorescence tracking is carried out to sample, with
Extend in the standing time of room temperature, can obviously observe that sample surfaces become coarse, granulating, while fluorescence by smooth
Transmitting is generated and is remarkably reinforced.This crystal form state transformation observation by way of visible light and UV light micro-imaging with photo
Shooting approach is recorded.See Fig. 5.The principle of the present invention effect picture is shown in Fig. 6.
The above embodiment is a preferred embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment
Limitation, other any changes, modifications, substitutions, combinations, simplifications made without departing from the spirit and principles of the present invention,
It should be equivalent substitute mode, be included within the scope of the present invention.
Claims (6)
1. using aggregation-induced emission to crystal growth and conversion fluorescent visual research method, it is characterised in that by utilizationization
It closes that fluorescence emission wavelengths under object different crystal forms state are different, different crystal forms crystal and/or right is distinguished using the method for fluorescence imaging
The conversion process of different crystal forms carries out dynamic imaging tracking；
The compound has structure shown in formula 1:
Wherein, R1It is each independently selected from sulphur atom or NH group；R2It is each independently selected from hydrogen atom, methyl, ethyl and methoxy
One of base.
2. according to claim 1 to crystal growth and convert fluorescent visual research method using aggregation-induced emission,
It is characterized by: described distinguish different crystal forms crystal by using the ultraviolet of 300~400nm wavelength using fluorescence imaging method
Light irradiation, visually observes, and according to the difference of the launch wavelength of different crystal forms, realizes the resolution to different crystal forms structural region；
Or it is described using fluorescence imaging method distinguish different crystal forms crystal by using 300~400nm wavelength ultraviolet lighting
It penetrates, is realized according to the difference of the launch wavelength of different crystal forms to different crystal forms structural region using Induced Fluorescence Microscopy
It differentiates.
3. according to claim 1 to crystal growth and convert fluorescent visual research method using aggregation-induced emission,
It is characterized by: the conversion process to different crystal forms carries out dynamic imaging tracking by using the purple of 300~400nm wavelength
Outer light irradiation carries out Time-resolved imaging using Induced Fluorescence Microscopy, and different crystal forms structure conversion process is moved in realization
State tracking.
4. according to claim 1 to crystal growth and convert fluorescent visual research method using aggregation-induced emission,
It is characterized by: when preparing the different crystal forms crystal of the compound, by the way that the compound is prepared as hot saturated solution, fastly
Speed or Slow cooling solution, obtain crystal；
Or by the way that the compound is prepared as room temperature saturated solution, slow solvent flashing, obtains crystal at room temperature；
Or it by melting the compound at high temperature, is then immediately placed in liquid nitrogen and is quickly cooled down, obtain amorphous state
Sample.
5. according to claim 4 to crystal growth and convert fluorescent visual research method using aggregation-induced emission,
It is characterized by: the high-temperature fusion is 200 DEG C；The solution uses single solvent or mixed solvent；The solvent packet
Include dimethyl sulfoxide, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide, acetonitrile, methanol, ethyl alcohol, normal propyl alcohol, isopropanol,
N-butanol, the tert-butyl alcohol, ethyl acetate, 1,4- dioxane, tetrahydrofuran, chloroform, methylene chloride, acetone, ether, petroleum ether,
At least one of n-hexane and hexamethylene.
6. described in claim 1 to crystal growth and convert fluorescent visual research method to machine using aggregation-induced emission
The growth course with the crystal threadiness aggregated structure aligned of tool scribing method preparation carries out fluorescent visual research
Using.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710303038.XA CN107192695B (en) | 2017-05-03 | 2017-05-03 | Using aggregation-induced emission to crystal growth and conversion fluorescent visual research method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710303038.XA CN107192695B (en) | 2017-05-03 | 2017-05-03 | Using aggregation-induced emission to crystal growth and conversion fluorescent visual research method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107192695A CN107192695A (en) | 2017-09-22 |
| CN107192695B true CN107192695B (en) | 2019-08-20 |
Family
ID=59873349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710303038.XA Active CN107192695B (en) | 2017-05-03 | 2017-05-03 | Using aggregation-induced emission to crystal growth and conversion fluorescent visual research method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107192695B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111372922B (en) | 2018-01-11 | 2022-06-28 | 香港科技大学 | Two-photon fluorescent compounds at ultra-low concentrations for lipid droplet-specific imaging in living cells and deep tissues |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103645193A (en) * | 2013-12-18 | 2014-03-19 | 中国科学院空间科学与应用研究中心 | Colloidal crystal growth detection control device |
| CN105567217A (en) * | 2015-12-15 | 2016-05-11 | 华南理工大学 | Multi-stimulus-response organic small-molecular luminescent material, and preparation and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645428B1 (en) * | 2000-04-27 | 2003-11-11 | Ondeo Nalco Company | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems |
-
2017
- 2017-05-03 CN CN201710303038.XA patent/CN107192695B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103645193A (en) * | 2013-12-18 | 2014-03-19 | 中国科学院空间科学与应用研究中心 | Colloidal crystal growth detection control device |
| CN105567217A (en) * | 2015-12-15 | 2016-05-11 | 华南理工大学 | Multi-stimulus-response organic small-molecular luminescent material, and preparation and application thereof |
Non-Patent Citations (5)
| Title |
|---|
| An aggregation-induced-emission platform for direct visualization of interfacial dynamic self-assembly;Li J et al.;《Angew Chem Int Ed Enql》;20141031;第13518-13522页 |
| Direct visualization of the two-step nucleation model by fluorescence color changes during evaporative crystallization from solution;Fuyukilto et al.;《Scientific reports》;20160308;第1-6页 |
| In situ microscopic observation of the crystallization process of molecular microparticle by fluorescence switching;Xin Ye et al.;《Crystallization》;20150514;第8087-8091页 |
| The fluorescent toolbox for assessing protein location and function;Ben N.G.Giepmans et al.;《Science》;20060414;第217-223页 |
| 两类具有不同发光机制的有机小分子荧光化合的合成及其光物理性能研究;巫鼎娥;《中国优秀硕士学位论文全文数据库》;20150701;第45-73页 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107192695A (en) | 2017-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | A tetraphenylethene-substituted pyridinium salt with multiple functionalities: synthesis, stimuli-responsive emission, optical waveguide and specific mitochondrion imaging | |
| He et al. | Growth of potassium nickel sulfate hexahydrate (KNSH) crystal and its characterization | |
| CN107681054A (en) | A kind of preparation method of perovskite crystal nano wire | |
| CN106542520B (en) | The preparation method of green orange red three fluorescence graphene quantum dot | |
| CN105883909B (en) | A kind of CsPbBrxI3‑xThe preparation method of nanometer rods | |
| Fedurco et al. | Single-Crystal X-ray Structure of C60. cntdot. 6SbPh3. A Well-Ordered Structure of C60 and a New Fullerene Solvent | |
| Pal et al. | A facile strategy for the fabrication of uniform CdS nanowires with high yield and its controlled morphological growth with the assistance of PEG in hydrothermal route | |
| CN106365128A (en) | Preparation method of magic-size nanocrystal substance | |
| CN107192695B (en) | Using aggregation-induced emission to crystal growth and conversion fluorescent visual research method | |
| Dang et al. | An efficient green approach to constructing adenine sulfate-derived multicolor sulfur-and nitrogen-codoped carbon dots and their bioimaging applications | |
| Deng et al. | Novel Bi19S27Br3 superstructures: facile microwave-assisted aqueous synthesis and their visible light photocatalytic performance | |
| Gu et al. | Preparation and photoluminescence of single-crystalline GdVO4: Eu3+ nanorods by hydrothermal conversion of Gd (OH) 3 nanorods | |
| Chen et al. | Waterproof, Self-Adhesive, and Large-Area Luminescent Perovskite–Polymer Fiber Membranes | |
| Guo et al. | Solvothermal synthesis and upconversion spectroscopy of monophase hexagonal NaYF4: Yb3+/Er3+ nanosized crystallines | |
| WO2018103629A1 (en) | Method for synthesizing chiral quantum rod based on circularly polarized light | |
| CN113373501A (en) | EuCl3Helper Cs3Cu2X5Method for growing perovskite single crystal | |
| CN109749736B (en) | Piezochromic material and preparation method and application thereof | |
| CN116375598B (en) | 4,4' -Azo dibenzoate phenanthroline dye eutectic and preparation method thereof | |
| CN112374965A (en) | Halogen bond eutectic material and preparation method and application thereof | |
| CN106276922A (en) | A kind of intersecting vertical SiO2nanometer rods and preparation method thereof | |
| CN1308415C (en) | Photoluminescence crystal material strontium borate lithium | |
| Xia et al. | A novel method for the direct synthesis of crystals of copper phthalocyanine | |
| CN110387099A (en) | A kind of tealeaf residue graphene-CuCeMOF-PVB composite material and preparation method and application | |
| Madhurambal et al. | Investigation on nucleation kinetics of urea–thiourea mixed crystal (UTMC) in methanol and absolute alcohol | |
| Cao et al. | Morphology and upconversion properties of rare-earth-doped MoO3 jellyfish-like plate microarchitecture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |